These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10681672)

  • 1. Long, slow dialysis.
    Charra B; Chazot C; Jean G; Laurent G
    Miner Electrolyte Metab; 1999; 25(4-6):391-6. PubMed ID: 10681672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From adequate to optimal dialysis long 3 x 8 hr dialysis: a reasonable compromise.
    Charra B
    Nefrologia; 2005; 25 Suppl 2():19-24. PubMed ID: 16050397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Length of Dialysis Session Is More Important Than Large Kt/V in Hemodialysis.
    Charra B; Jean G; Chazot C; Vanel T; Terrat JC; Laurent G
    Home Hemodial Int; 1999 Jan; 3(1):16-22. PubMed ID: 28455858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of blood pressure in long slow hemodialysis.
    Charra B
    Blood Purif; 1994; 12(4-5):252-8. PubMed ID: 7865184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment options to intensify hemodialysis.
    Haag-Weber M
    Kidney Blood Press Res; 2003; 26(2):90-5. PubMed ID: 12771532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long 3 x 8 hr dialysis: a three-decade summary.
    Charra B; Chazot C; Jean G; Hurot JM; Vanel T; Terrat JC; VoVan C
    J Nephrol; 2003; 16 Suppl 7():S64-9. PubMed ID: 14733303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing dry weight and hypertension in dialysis patients: still a challenge for the nephrologist in 2009?
    Chazot C
    J Nephrol; 2009; 22(5):587-97. PubMed ID: 19809991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volume control, blood pressure and cardiovascular function. Lessons from hemodialysis treatment.
    Charra B; Chazot C
    Nephron Physiol; 2003; 93(4):p94-101. PubMed ID: 12759570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of dialysis sodium gradient on intradialytic hypertension: an observational study.
    Movilli E; Camerini C; Gaggia P; Zubani R; Feller P; Poiatti P; Pola A; Carli O; Valzorio B; Cancarini G
    Am J Nephrol; 2013; 38(5):413-9. PubMed ID: 24216674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a magic in long nocturnal dialysis?
    Charra B
    Contrib Nephrol; 2005; 149():100-106. PubMed ID: 15876833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of salt intake in hemodialysis].
    Maduell F; Navarro V
    Nefrologia; 2001; 21(1):71-7. PubMed ID: 11344965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre to post-dialysis plasma sodium change better predicts clinical outcomes than dialysate to plasma sodium gradient in quotidian hemodialysis.
    Thomson BK; Huang SH; Leitch RE; Dixon S; Heidenheim P; Suri RS; Chan CT; Lindsay RM
    Hemodial Int; 2013 Oct; 17(4):548-56. PubMed ID: 23551488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypertension in hemodialysis patients in Andalucia].
    García Cortés MJ; Ceballos M;
    Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis and management of intradialytic hypertension.
    Dousdampanis P; Trigka K; Giannopoulos A; Fourtounas C
    Curr Hypertens Rev; 2014; 10(3):171-6. PubMed ID: 25563732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Control of arterial hypertension by means of a regimen of hemodialysis on alternate days (HDAA or EODD: "Every Other Day Dialysis") versus 2 conventional regiments of 4 and 5 hours per session 3 times a week with 72 hours without sessions during the weekends].
    Lozano A; Benavides B; Quirós P; Jiménez-Moreno J; Figueroa E; Fernández-Marchena D; García-Pérez MA; Fernández-Ruiz E
    Nefrologia; 2006; 26(6):695-702. PubMed ID: 17227247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-pharmacologic treatment of arterial hypertension in hemodialysis patients].
    Chazot C; Charra B
    Nephrol Ther; 2007 Oct; 3 Suppl 3():S178-84. PubMed ID: 18340684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood Pressure and Mortality in Long-Term Hemodialysis-Time to Move Forward.
    Georgianos PI; Agarwal R
    Am J Hypertens; 2017 Mar; 30(3):211-222. PubMed ID: 27661097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension in Pediatric Dialysis Patients: Etiology, Evaluation, and Management.
    Munshi R; Flynn JT
    Curr Hypertens Rep; 2018 Jun; 20(7):61. PubMed ID: 29884913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodialysis-associated hypertension: pathophysiology and therapy.
    Hörl MP; Hörl WH
    Am J Kidney Dis; 2002 Feb; 39(2):227-44. PubMed ID: 11840363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment time and ultrafiltration rate are more important in dialysis prescription than small molecule clearance.
    Twardowski ZJ
    Blood Purif; 2007; 25(1):90-8. PubMed ID: 17170543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.